Compound H26, a derivative of corosolic acid, functions as Hypoglycemic agent 3. It exhibits lipid-lowering and significant blood glucose-reducing properties, making it a potential hypoglycemic drug. Hypoglycemic agent 3 targets MCCC1 to mitigate insulin resistance, and may be useful in researching type 2 diabetes.
Molecular Weight:
529.751
Formula:
C32H51NO5
Target:
PI3K|||Akt|||NF-kappaB
T204686
* VAT and and shipping costs not included. Errors and price changes excepted
